rxstat › Shortages › Methylphenidate

Methylphenidate shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Methylphenidate products are in shortage in Canada (7 of 59 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 3, 2026.
Products affected
7 / 59
In shortage since
Jan 30, 2018
Est. full return
Oct 3, 2026
Reports on file
246
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PMS-METHYLPHENIDATE CR
80MG · CAPSULE (EXTENDED RELEASE) · PHARMASCIENCE INC
DIN 02537036 · since Dec 22, 2025, est. end Aug 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMS-METHYLPHENIDATE CR
30MG · CAPSULE (EXTENDED RELEASE) · PHARMASCIENCE INC
DIN 02536986 · since Jun 22, 2026, est. end Aug 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMS-METHYLPHENIDATE CR
15MG · CAPSULE (EXTENDED RELEASE) · PHARMASCIENCE INC
DIN 02536951 · since May 22, 2026, est. end Oct 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-METHYLPHENIDATE ER-C
54MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02315092 · since Jan 30, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-METHYLPHENIDATE ER-C
36MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02315084 · since Jan 30, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-METHYLPHENIDATE ER-C
27MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02315076 · since Jan 30, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-METHYLPHENIDATE ER-C
18MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02315068 · since Jan 30, 2018, no end estimate · Disruption of the manufacture of the drug.
Resolved
PMS-METHYLPHENIDATE CR
10MG · CAPSULE (EXTENDED RELEASE) · PHARMASCIENCE INC
DIN 02536943 · ended Jul 6, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-METHYLPHENIDATE CR
60MG · CAPSULE (EXTENDED RELEASE) · PHARMASCIENCE INC
DIN 02537028 · ended Jul 6, 2026 · Disruption of the manufacture of the drug.
Resolved
BIPHENTIN
20MG · CAPSULE (EXTENDED RELEASE) · ELVIUM LIFE SCIENCES
DIN 02277158 · ended Jun 25, 2026 · Delay in shipping of the drug.
Resolved
PMS-METHYLPHENIDATE CR
20MG · CAPSULE (EXTENDED RELEASE) · PHARMASCIENCE INC
DIN 02536978 · ended Jun 24, 2026 · Disruption of the manufacture of the drug.
Resolved
QUILLIVANT ER CHEWABLE TABLETS
40MG · TABLET (CHEWABLE, EXTENDED-RELEASE) · KYE PHARMACEUTICALS INC.
DIN 02541629 · ended Apr 27, 2026 · Demand increase for the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Methylphenidate is currently affected by 7 active shortage reports filed with Health Canada by PHARMASCIENCE INC, TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Methylphenidate is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).

Recent changes

Common questions

When will Methylphenidate be back in stock in Canada?

The latest manufacturer estimate is Oct 3, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Methylphenidate in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (psychostimulants and nootropics)

Partial shortageAtomoxetine13 of 63 reported products affected · est. return Dec 31, 2026Partial shortageDextroamphetamine2 of 6 reported products affected · est. return Jul 20, 2026Partial shortageLisdexamfetamine3 of 18 reported products affected · est. return Jul 24, 2026Partial shortageMixed Salts Amphetamine3 of 25 reported products affected · est. return Jun 19, 2026Partial shortageModafinil1 of 6 reported products affectedNo current shortageCaffeine

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.